Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Cancers|December 9, 2023
Two Faces of Glutaminase GLS2 in CarcinogenesisJoanna Buczkowska, Monika SzeligaNeurochemistry International|May 12, 2009
Glutamine in neoplastic cells: focus on the expression and roles of glutaminasesMonika Szeliga, Marta Obara-MichlewskaCancers|February 5, 2020
Targeting Glutamine Addiction in GliomasMarta Obara-Michlewska, Monika SzeligaBiochemical and Biophysical Research Communications|January 31, 2026
Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cellsKamila Szumska, Fatmanur Sabir, Monika SzeligaNeurochemistry International|December 7, 2007
Regulation of pH in the mammalian central nervous system under normal and pathological conditions: facts and hypothesesMarta Obara, Monika Szeliga, Jan AlbrechtBioorganic Chemistry|October 19, 2020
Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathwayMonika Szeliga, Monika Karpińska, Radosław Rola, et al.Cancers|January 24, 2019
Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT PathwayEwelina Majewska, Javier Márquez, Jan Albrecht, et al.Cancers|July 31, 2020
Erratum: Majewska, E. et al. Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway. Cancers 2019, 11, 115Ewelina Majewska, Javier Márquez, Jan Albrecht, et al.Journal of Neurochemistry|August 15, 2012
Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agentsMonika Szeliga, Agata Zgrzywa, Marta Obara-Michlewska, et al.Neuroscience Letters|January 25, 2005
Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomasMonika Szeliga, Marta Sidoryk, Ewa Matyja, et al.Pageof 4